ID
26687
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Substance use
Keywords
Versions (2)
- 9/21/17 9/21/17 -
- 10/23/17 10/23/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 23, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Substance use GSK study Chronic Coronary Heart Disease NCT00799903
Substance use GSK study Chronic Coronary Heart Disease NCT00799903
Description
History of tobacco use details (baseline)
Description
cigarettes smoked per day
Data type
integer
Description
years of tobacco use
Data type
integer
Measurement units
- years
Description
This item will be calcuated by InForm using the following formula: Average number of cigarettes smoked per day divided by 20 and then multiplied by number of years smoked. Round up/down to nearest integer.
Data type
integer
Description
Current tobacco use (annual visit)
Description
Current tobacco use details (annual visit)
Description
Current tobacco use (end of treatment/early withdrawal)
Description
Current tobacco use details (end of treatment/early withdrawal)
Description
Alcohol intake (liver event)